← Back to patent-cliff list
HY-072808
Tier C — Watch / tradeHY-072808
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PDE4
Indications (approved)：Eczema, Atopic dermatitis
Regional status
US
-
EU
-
China
Phase III
2024-04-17
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of HY-072808?
Approved indications include: Eczema, Atopic dermatitis.
When does the HY-072808 patent expire?
No public expiry year is available for HY-072808 yet; this page updates once verified.
How do I get a quote for HY-072808 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01